Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001628280-26-011983
Filing Date
2026-02-26
Accepted
2026-02-26 07:27:21
Documents
151
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 10-K cbio-20251231.htm   iXBRL 10-K 2361797
2 EX-4.3 ex43-cbioxdescriptionofsec.htm EX-4.3 52703
3 EX-4.4 ex44-crescentxformofparasc.htm EX-4.4 99272
4 EX-10.7 1 ex1071-crescentxoptionawar.htm EX-10.7 1 51864
5 EX-10.7 2 ex1072-crescentxoptionawar.htm EX-10.7 2 53448
6 EX-10.7 3 ex1073-crescentxoptionawar.htm EX-10.7 3 51050
7 EX-10.7 4 ex1074-crescentxrsugrantag.htm EX-10.7 4 40633
8 EX-10.7 5 ex1075-crescentxrsugrantag.htm EX-10.7 5 40287
9 EX-10.7 6 ex1076-crescentxrsugrantag.htm EX-10.7 6 38978
10 EX-10.9 1 ex1091-crescentx2025induce.htm EX-10.9 1 48571
11 EX-10.23 ex1023-crescentxofferlette.htm EX-10.23 82685
12 EX-10.25 ex1025-cbioxnonxdirectorco.htm EX-10.25 19173
13 EX-19 ex19-crescentxinsidertradi.htm EX-19 85506
14 EX-23.1 ex231-cbioconsentdraft.htm EX-23.1 1846
15 EX-31.1 exhibit-311.htm EX-31.1 9554
16 EX-31.2 exhibit-312.htm EX-31.2 9880
17 EX-32.1 exhibit-321.htm EX-32.1 3928
18 EX-32.2 exhibit-322.htm EX-32.2 3825
19 EX-97.1 ex971-crescentxclawbackpol.htm EX-97.1 28953
25 cbio-20251231_g1.jpg GRAPHIC 335176
26 cbio-20251231_g10.jpg GRAPHIC 444791
27 cbio-20251231_g11.jpg GRAPHIC 1064148
28 cbio-20251231_g12.jpg GRAPHIC 315118
29 cbio-20251231_g13.jpg GRAPHIC 360338
30 cbio-20251231_g14.jpg GRAPHIC 397335
31 cbio-20251231_g15.jpg GRAPHIC 394062
32 cbio-20251231_g16.jpg GRAPHIC 140716
33 cbio-20251231_g17.jpg GRAPHIC 217549
34 cbio-20251231_g18.jpg GRAPHIC 436559
35 cbio-20251231_g19.jpg GRAPHIC 242065
36 cbio-20251231_g2.jpg GRAPHIC 2091254
37 cbio-20251231_g20.jpg GRAPHIC 255135
38 cbio-20251231_g21.jpg GRAPHIC 245712
39 cbio-20251231_g22.jpg GRAPHIC 1693711
40 cbio-20251231_g23.jpg GRAPHIC 363536
41 cbio-20251231_g3.jpg GRAPHIC 700658
42 cbio-20251231_g4.jpg GRAPHIC 292411
43 cbio-20251231_g5.jpg GRAPHIC 237082
44 cbio-20251231_g6.jpg GRAPHIC 200255
45 cbio-20251231_g7.jpg GRAPHIC 646984
46 cbio-20251231_g8.jpg GRAPHIC 469539
47 cbio-20251231_g9.jpg GRAPHIC 306321
48 image_0.jpg GRAPHIC 453414
49 image_0a.jpg GRAPHIC 453414
50 image_0b.jpg GRAPHIC 453414
  Complete submission text file 0001628280-26-011983.txt   42073429

Data Files

Seq Description Document Type Size
20 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cbio-20251231.xsd EX-101.SCH 74235
21 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cbio-20251231_cal.xml EX-101.CAL 91271
22 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cbio-20251231_def.xml EX-101.DEF 479125
23 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cbio-20251231_lab.xml EX-101.LAB 847232
24 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cbio-20251231_pre.xml EX-101.PRE 716003
154 EXTRACTED XBRL INSTANCE DOCUMENT cbio-20251231_htm.xml XML 1013894
Mailing Address 300 FIFTH AVENUE WALTHAM MA 02451
Business Address 300 FIFTH AVENUE WALTHAM MA 02451 617-430-5595
CRESCENT BIOPHARMA, INC. (Filer) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36177 | Film No.: 26681704
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)